Alpha Tau Medical DRTS
NASDAQ DRTS
$15.03 +0.41 (+2.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

Alpha Tau Medical (DRTS) Invested Capital (2023 - 2026)

Analysis

Alpha Tau Medical (DRTS) Invested Capital (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Alpha Tau Medical 1.21 Bn 1.11 Bn - 50.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.86 Mn
Mar 31, 2026 75.76 Mn
Dec 31, 2025 83.45 Mn
Sep 30, 2025 83.74 Mn
Jun 30, 2025 92.66 Mn
Mar 31, 2025 61.80 Mn
Dec 31, 2024 68.23 Mn
Sep 30, 2024 74.88 Mn
Jun 30, 2024 79.43 Mn
Mar 31, 2024 84.59 Mn
Dec 31, 2023 90.09 Mn